$412.78
11.842.95%
最終更新: Oct 9, 4:56 PM
$411.70
10.762.68%
Benzinga
Benzinga
Benzinga
日曜日, 10 11
Benzinga
© 2026 Benzinga | All Rights Reserved
Elevance Health (ELV) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Elevance Health (ELV) は、9 10, 2026日にfiscal yearの2026に関するガイダンスを直近で発表しました。同社は当期の売上高をの範囲と予想しています。
以前のガイダンスと比較すると、Elevance HealthはEPS見通しを以前の範囲である維持から$30 - $30に引き上げました。
Elevance Healthは、12から1 25, 2023の間に11 10, 2025ガイダンスの更新を発表しました。During this period, the company raised its outlook 1 time and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $6.20 | $10.74 | $3.10 | $4.96 |
| Actual | $7.45 | $12.58 | $3.33 | $6.03 |
| Surprise | +20.2% | +17.1% | +7.42% | +21.6% |
| Revenue | ||||
| Estimate | $48.59B | $47.98B | $49.47B | $49.51B |
| Actual | $49.83B | $49.49B | $49.31B | $50.09B |
| Surprise | +2.54% | +3.15% | -0.32% | +1.17% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $4.68 | $2.45 | $11.88 | $7.79 |
| Revenue | ||||
| Consensus | $49.05B | $48.05B | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Jul 15, 2026 | $7.45 | $6.20 | 20.2 % |
| Q1 | Apr 22, 2026 | $12.58 | $10.74 | 17.1 % |
| Q4 | Jan 28, 2026 | $3.33 | $3.10 | 7.42 % |
| Q3 | Oct 21, 2025 | $6.03 | $4.96 | 21.6 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Jul 15, 2026 | $49.83B | $48.59B | 2.54 % |
| Q1 | Apr 22, 2026 | $49.49B | $47.98B | 3.15 % |
| Q4 | Jan 28, 2026 | $49.31B | $49.47B | -0.32 % |
| Q3 | Oct 21, 2025 | $50.09B | $49.51B | 1.17 % |